Drug Shortage Report for APO-GLICLAZIDE

Last updated on 2018-05-22 History
Report ID 26159
Drug Identification Number 02245247
Brand name APO-GLICLAZIDE
Common or Proper name GLICLAZIDE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-16
Estimated end date 2018-06-22
Actual end date 2018-05-21
Shortage status Resolved
Updated date 2018-05-22
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2018-05-22 French Compare
v26 2018-05-22 English Compare
v25 2018-04-16 French Compare
v24 2018-04-16 English Compare
v23 2018-03-06 French Compare
v22 2018-03-06 English Compare
v21 2018-03-06 English Compare
v20 2018-03-05 French Compare
v19 2018-03-05 English Compare
v18 2018-03-05 English Compare
v17 2018-02-27 French Compare
v16 2018-02-27 English Compare
v15 2018-02-12 French Compare
v14 2018-02-12 English Compare
v13 2017-12-19 French Compare
v12 2017-12-19 English Compare
v11 2017-12-19 French Compare
v10 2017-12-19 English Compare
v9 2017-11-22 French Compare
v8 2017-11-22 English Compare

Showing 1 to 20 of 27